Autonomix Medical (AMIX) Net Equity Issued and Repurchased (2023 - 2025)

Autonomix Medical's (AMIX) quarterly Net Equity Issued and Repurchased came in at $1.3 million in Q4 2025, up 6290.48% on a QoQ basis from -$21000.0 in Q3 2025.

Autonomix Medical (AMIX) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends

Autonomix Medical (AMIX) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $1.3 million in Q4 2025.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $3.4 million, a N/A change from a year earlier, with the FY2024 full-year figure at $2.8 million, up 320.74% from the prior year.
  • Net Equity Issued and Repurchased for Q4 2025 stood at $1.3 million, up from -$21000.0 in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for AMIX reached as high as $2.8 million in Q2 2023 and fell as low as -$21000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Autonomix Medical 1.03 Mn 1.03 Mn - 1.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.30 Mn
Dec 31, 2025 1.30 Mn
Sep 30, 2025 -21,000.00
Sep 30, 2025 -21,000.00
Jun 30, 2025 2.12 Mn
Jun 30, 2025 2.12 Mn
Mar 31, 2025 2,000.00
Mar 31, 2025 2,000.00
Jun 30, 2023 2.84 Mn
Jun 30, 2023 2.84 Mn
Mar 31, 2023 675,000.00
Mar 31, 2023 675,000.00